- Praxis Precision Medicines Inc Extraordinary Shareholders Meeting TranscriptNov 06, 2023
- Praxis Precision Medicines Inc R&D Day TranscriptOct 02, 2023
- Praxis Precision Medicines Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Praxis Precision Medicines Inc at Needham Healthcare Conference (Virtual) TranscriptApr 17, 2023
- Praxis Precision Medicines Inc Essential1 Topline Results Call TranscriptMar 03, 2023
- Praxis Precision Medicines Inc at Citi Biopharma Co-Panel Day (Virtual) - Mood Disorders/Mental Health Panel TranscriptMay 18, 2022
- Praxis Precision Medicines Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 Praxis Precision Medicines Inc Earnings Call TranscriptMay 09, 2022$110.85 (-8.54%)Earnings
- Praxis Precision Medicines Inc Epilepsy Day TranscriptApr 27, 2022
- Praxis Precision Medicines Inc at Cowen Health Care Conference (Virtual) TranscriptMar 07, 2022
- Q4 2021 Praxis Precision Medicines Inc Earnings Call TranscriptFeb 28, 2022$196.5 (-1.73%)Earnings
- Praxis Precision Medicines Inc Movement Disorder Day TranscriptDec 17, 2021
- Q3 2021 Praxis Precision Medicines Inc Earnings Call TranscriptNov 03, 2021$329.55 (+1.24%)Earnings
- Praxis Precision Medicines Inc at Citi BioPharma Conference (Virtual) TranscriptSep 08, 2021
- Praxis Precision Medicines Inc Annual Shareholders Meeting TranscriptJun 08, 2021
- Q4 2020 Praxis Precision Medicines Inc Earnings Call TranscriptMar 17, 2021$637.65 (+2.56%)Earnings
Q3 2021 Praxis Precision Medicines Inc Earnings Call Transcript
Good day, and welcome to Praxis Third Quarter 2021 Update Call. As a reminder, this call may be recorded.
I would now like to turn the call over to Alex Kane, Vice President of Investor Relations and Corporate Communications.
Thank you. Good morning, everyone, and thank you for joining us today to discuss Praxis Third Quarter 2021 Corporate Update.
With me on today's call is our President and Chief Executive Officer, Marcio Souza; our Chief Medical Officer, Bernard Ravina; and our Chief Financial Officer, Tim Kelly. Please note that today's prepared remarks will focus on recent business and pipeline progress, along with a brief update on our third quarter 2021 financial results. We will be referring to supplement slides throughout today's prepared remarks, which are posted on the Events and Presentations section of our Investor Relations website. So please access them now if you have not already done so.
Before we proceed, I would like to remind
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)